Jones Financial Companies’s CERo Therapeutics CERO Stock Holding History

Jones Financial Companies’s Portfolio CERO Stock Details CERO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-3	Closed	-$16	–	4622
2025 Q3	$16	Hold	3	–	–	﹤0.01%	4205
2025 Q2	$29	Buy	+3	New	+$37	﹤0.01%	3988

Jones Financial Companies's CERO Position: Q4 2025 in Review

Jones Financial Companies sold out of CERo Therapeutics (CERO) in Q4 2025, closing a stake of 3 shares — an estimated $16 sold.

Jones Financial Companies first reported a position in CERO in Q2 2025 and held it in 2 quarters. The position peaked at $29 in Q2 2025. 0 funds tracked by Wall St. Rank hold CERO as of Q4 2025.

Jones Financial Companies reported no remaining CERo Therapeutics position as of Q4 2025 after selling out during the quarter.
Jones Financial Companies sold 3 CERo Therapeutics shares in Q4 2025, an estimated $16.
Jones Financial Companies first reported a position in CERo Therapeutics in Q2 2025 and held it in 2 quarters.
Jones Financial Companies's CERo Therapeutics position peaked at $29 in Q2 2025.
0 funds tracked by Wall St. Rank held CERo Therapeutics as of Q4 2025.

Based on Jones Financial Companies's 13F filing for Q4 2025, filed 17 Feb 2026.